Foundation of the European CRO Federation (EUCROF)
At Amsterdam Airport delegates representing the local CRO associations from the Netherlands, Germany, Czech Republic, France, Spain, Italy and United Kingdom were represented for the inaugural meeting of the European CRO Federation (EUCROF).
On Wednesday 19 October 2005 the European CRO Federation was founded.
At Amsterdam Airport delegates representing the local CRO associations from the Netherlands, Germany, Czech Republic, France, Spain, Italy and United Kingdom were represented for the inaugural meeting of the European CRO Federation (EUCROF).
The aims and objectives of EUCROF were defined as:
- Promote the European Union for clinical research.
- Harmonise and actively promote the highest quality standards of clinical research.
- Focussing their strengths to bring more productive discussions with European bodies (EMEA/EU Parliament/Commission).
- Exchange of information between the members.
- Propose thematic discussions with Pharmaceutical Industry representatives e.g. PCMG (Pharmaceutical Contract Management Group) to enhance business relations and identify common causes.
- Develop transcontinental relationships with other Associations, eg ACRO (USA), JCROA (Japan).
The first elected President of EUCROF is Mr. Pieter Guelen from ACRON (The Netherlands). As Vice-President Mrs. Dagmar Chase from BVMA (Germany) was elected. Mr. Dominique Gerbet from AFCROs (France) was elected as treasurer and Mr. Jos Garcia from AECIC (Spain) was elected as general board member. The Federation will be established in the Netherlands.
Members of EUCROF are national associations of Clinical Research Organisations (CROs). The current 7 associations are representative of the local CROs network and represent as of today 250 companies.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
